Home » Stocks » ACXP

Acurx Pharmaceuticals, Inc. (ACXP)

Acurx Pharmaceuticals will go public soon. The estimated IPO date is June 25, 2021.
Stock Price: $5.00 - $7.00
Current IPO price range
Market Cap 57.25M
Revenue (ttm) n/a
Net Income (ttm) -4.80M
Shares Out 9.54M
EPS (ttm) -0.50
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day n/a
Last Price n/a
Previous Close n/a
Change ($) n/a
Change (%) n/a
Day's Open n/a
Day's Range n/a
Day's Volume n/a
52-Week Range n/a

News

Acurx Pharmaceuticals, Inc. has filed to go public with an IPO on the NASDAQ.

3 weeks ago - SEC

About ACXP

Acurx Pharmaceuticals is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization (“WHO”), the U.S. Centers for Disease Control and Prevention (“CDC”), and the U.S. Food and Drug Administration (“FDA”). Priority pathogens are those which require new antibiotics to address the worldwide crisis of antimicrobial resistance (“AMR”), as identified by the WHO, CDC and FDA. The WHO recently stated that growing antimic... [Read more...]

Industry
Pharmaceutical Preparations
IPO Date
Jun 25, 2021
CEO
David P. Luci
Employees
2
Stock Exchange
NASDAQ
Ticker Symbol
ACXP
Full Company Profile

Financial Performance

Financial Statements